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ABSTRACT 
The objective of this study was to investigate the effect of ethanolic 
extract and petroleum ether extract of Zingiber officinale on the levels 
of plasma total cholesterol, high density lipoprotein (HDL-C), low 
density lipoprotein (LDL), triglycerides in an induced 
hypercholesterolemic rats and on the level of glucose in an induced 
hyperglycemic Wistar albino rats. 
Wistar albino rats of either sex were used in the present experiments. 
They 
were divided into five and three groups of six rats each for the first   and 
the second experiment respectively. In the first experiment groups A, B, 
C and D: received basal diet +1% cholesterol.Ethanolic extract of 
Z.officinale was administrated orally to rats of group A and petroleum 
ether extract to the rats of group B,both at dose of 200 mg/kg body 
weight. The rats of group C received polyethylene glycol (PEG) at dose 
of 200 mg/kg body weight. Group E: received only basal diet. Blood 
samples were collected after two weeks and 4 weeks. 
The three groups A, B and C of the second experiment received basal 
diet and they were injected intraperitonially with 50% glucose solution 
at dose of 2g/kg body weight and immediately after injection, distilled 
water was administered orally to group A, the Zingiber Officinale 
ethanolic extract was administered orally at a dose of 200 mg/kg body 
weight to group B and group C was given a dose of 10 mg/kg body 
weight Glibenclamide. Plasma glucose level of all groups was 
monitored at 0h, 1h, 2h, and 4h.  
In the first experiment Z.officinale ethanolic extract and petroleum ether 
increased total cholesterol numerically at week 2 and 4.However both 
extracts   had no significant effect in HDL level at week 2 and 4. 
 13
Ethanolic extract caused numerical reduction in LDL level at week 2 
and 4.However petroleum ether extract caused non significant increase 
in LDL level. At week 2, the petroleum ether extract significantly 
increased triglyceride but ethanolic extract had no effect and both 
extracts had no significant effect on triglyceride level at week 4.The 
polyethylene glycol  increased significantly the cholesterol and LDL 
level at week 2 and cholesterol at week 4 and increase numerically LDL 
at week 4. 
In the second experiment Z.officinale ethanolic extract did not show 
significant hypoglycemic effect when compared to control while 
conventional anti diabetic drug glibenclamide reduced significantly the 
level of blood glucose at 2 and 4 hour. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 ﺨﻼﺼﺔ ﺍﻻﻁﺭﻭﺤﺔ
 ﻋﻠـﻰ ﻤـﺴﺘﻭﻯ ﺍﺠﺭﻴﺕ ﻫﺫﺓ ﺍﻟﺩﺭﺍﺴﺔ ﻋﻠﻰ ﻤﺠﻤﻭﻋﺔ ﻤﻥ ﺍﻟﻔﺌﺭﺍﻥ ﻟﻤﻌﺭﻓـﺔ ﺍﺜـﺭ ﺍﻟﺠﻨﺯﺒﻴـل 
  ﻜﻭﻟـﺴﺘﺭﻭل  ﺍﻟﻼﻴﺒﻭﺒﺭﻭﺘﻴﻥ ﻭ ﻤﻨﺨﻔﺽ ﺍﻟﻜﺜﺎﻓﻪ ﻜﻭﻟﺴﺘﺭﻭلﺍﻟﻜﻠﻰ ﻭﺍﻟﻼﻴﺒﻭﺒﺭﻭﺘﻴﻥ ﺍﻟﻜﻭﻟﺴﺘﺭﻭل
. ﺘﻡ ﺘﻘﺴﻴﻡ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﻰ ﺘﺠﺭﺒﺘﻴﻥ.ﻭﺍﻟﺠﻠﺴﺭﻴﺩﺍﺕ ﺍﻟﺜﻼﺜﻴﺔ ﻭﺍﻟﺠﻠﻜﻭﺯﻓﻰ ﺩﻡ ﺍﻟﺠﺭﺫﺍﻥ ﻋﺎﻟﻰ ﺍﻟﻜﺜﺎﻓﻪ
 ﻤﻨﻬﺎ   ﺒﻐﺫﺍﺀ ﺍﻟﻔﺌﺭﺍﻥ ﻤﻀﺎﻑ ﺍﻟﻴـﻪ ﺒـﺩﺭﺓ 4 ﻤﺠﻤﻭﻋﺎﺕ ﺘﻤﺕ ﺘﻐﺫﻴﺔ 5: ﺍﻻﻭﻟﻰ ﺘﺸﺘﻤل ﻋﻠﻰ 
 ﻭﻤـﺴﺘﺨﻠﺹ A ﻟﻤﺠﻤﻭﻋـﺔ ﺍﻟﻔﺌـﺭﺍﻥ ﻰﺍﻟﻜﻠﻭﺴﺘﺭﻭل ﻭﺘﻡ ﺘﺠﺭﻴﻌﻬﺎ ﺒﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤﻭل ﺍﻻﻴﺜﻠ 
 C ﻟﻠﻤﺠﻤﻭﻋـﺔ  ﻭﺍﻟﺒـﻭﻟﻰ ﺍﻴﺜـﺎﻟﻴﻥ ﺠﻼﻴﻜـﻭل B ﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻔﺌﺭﺍﻥ ﺍﻟﺒﺘﺭﻭﻟﻴﻡ ﺍﻴﺜﺭ ﻟﻠﺠﻨﺯﺒﻴل 
ﻴﻭﻤﻴﺎ ﻟﻤـﺩﺓ ﺸـﻬﺭ ( ﻜﻨﺘﺭﻭل) ﻭ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺭﺍﺒﻌﺔ ﻻﺘﺘﻠﻘﻰ ﻤﺤﻠﻭل ﻜﺠﻡ/ﺠﻡ002ﻭﺍﻟﺠﺭﻋﺔ  
ﺨـﺫ ﻭﺘﻡ ﺍ . ﺘﺘﻠﻘﻰ ﻓﻘﻁ ﻏﺫﺍﺀ ﺍﻟﻔﺌﺭﺍﻥ  ﻭﻤﻘﺎﺭﻨﺔ  ﻤﺠﻤﻭﻋﺔ ﻀﺒﻁ ﺍﺴﺘﺨﺩﻤﺕﻭﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺨﺎﻤﺴﺔ ﺍ 
 .ﻋﻴﻨﺎﺕ ﺍﻟﺩﻡ ﺒﻌﺩ ﺍﺴﺒﻭﻋﻴﻥ ﻭﺍﺭﺒﻌﺔ ﺍﺴﺎﺒﻴﻊ
ﻭﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺜﺎﻨﻴﺔ ﺘﻡ ﺘﻘﺴﻴﻡ ﺍﻟﻔﺌﺭﺍﻥ ﺍﻟﻰ ﺜﻼﺙ ﻤﺠﻤﻭﻋﺎﺕ ﺘﻤﺕ ﺘﻐﺫﻴﺘﻬﺎ ﺒﻐﺫﺍﺀ ﺍﻟﻔﺌﺭﺍﻥ ﻭﺘﻡ ﺤﻘﻨﻬﺎ 
 ﻭﻤﺒﺎﺸـﺭﺓ ﺘـﻡ ﺘﺠﺭﻴـﻊ ﻜﺠﻡ/ ﺠﻡ002 ﺘﺤﺕ ﺍﻟﺒﻁﻥ ﺒﺠﺭﻋﺔ ﻭﻗﺩﺭﻫﺎ% 05ﺒﻤﺤﻠﻭل ﺍﻟﺠﻠﻜﻭﺯ 
ﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤـﻭل ﺍﻻﻴﺜﻠـﻰ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻻﻭﻟﻰ ﺒﺎﻟﻤﺎﺀ ﺍﻟﻤﻘﻁﺭﻭﺘﻡ ﺘﺠﺭﻴﻊ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺜﺎﻨﻴﺔ ﺒﺎ 
 ﻋـﻼﺝ ﺩﻭﺍﺀ)ﻜﺠﻡ ﻭﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺜﺎﻟﺜﺔ ﺘﻡ ﺍﻋﻁﺎﺌﻬﺎ ﺍﻟﻜﻠﻴﺒﻥ ﻜﻼﻤﺎﻴﺩ / ﺠﻡ 002ﻟﻠﺠﻨﺯﺒﻴل ﺍﻟﺠﺭﻋﺔ 
ﻜﺠﻡ ﻭﺘﻡ ﻗﻴﺎﺱ ﻤﺴﺘﻭﻯ ﺍﻟﺠﻠﻜﻭﺯ ﻓﻰ ﺍﻟﺴﺎﻋﺔ ﺼﻔﺭ ﻭ ﺍﻻﻭﻟـﻰ / ﺠﻡ 01ﺍﻟﺠﺭﻋﺔ( ﺍﻟﺴﻜﺭﻯ ﻤﺭﺽ
  .ﻭﺍﻟﺜﺎﻨﻴﺔ ﻭﺍﻟﺭﺍﺒﻌﺔ
 ﻟﻠﺠﻨﺯﺒﻴـل ﺘﺭﻭﻟﻴﻡ ﺍﻻﻴﺜﺭ  ﺍﻟﺒ ﻟﻤﺴﺘﺨﻠﺹﺍ  ﺍﻻﻴﺜﻠﻰ ﻭ ﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤﻭﻟﻰ ﺍﻓﻰ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻻﻭﻟﻰ   
 ﻋﻠﻰ ﻤﺴﺘﻭﻯ ﺍﻟﻼﻴﺒﻭﺒﺭﻭﺘﻴﻥ ﻴﻭﺠﺩ ﺍﺜﺭ ﻤﻌﻨﻭﻯ  ﻭﻻ  ﺍﻟﻰ ﺯﻴﺎﺩﺓ ﺭﻗﻤﻴﺎ ﻓﻰ  ﻤﺴﺘﻭﻯ ﺍﻟﻜﻠﺴﺘﺭﻭل ﺍﺩﻴﺎ
  ﺍﻻﻴﺜﻠﻰ ﺍﺩﻯ ﺍﻟﻰ ﺨﻔﺽ ﺭﻗﻤﻴﺎ ﻓﻰ ﻤـﺴﺘﻭﻯ ﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤﻭﻟﻰﺍ ﻭ . ﻋﺎﻟﻰ ﺍﻟﻜﺜﺎﻓﻪ ﻜﻭﻟﺴﺘﺭﻭل
ﺍﻴﺜﺭ ﺍﺩﻯ ﻭﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﺒﺘﺭﻭﻟﻴﻡ 4ﻭ2 ﺒﻌﺩ ﺍﻻﺴﺒﻭﻉ  ﻤﻨﺨﻔﺽ ﺍﻟﻜﺜﺎﻓﻪ  ﻜﻭﻟﺴﺘﺭﻭل ﺍﻟﻼﻴﺒﻭﺒﺭﻭﺘﻴﻥ
51 
ﻭﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﺒﺘﺭﻭﻟﻴﻡ ﺍﻴﺜﺭ ﺍﺩﻯ ﺍﻟﻰ ﺫﻴـﺎﺩﺓ ﻤﻌﻨﻭﻴـﺔ ﻓـﻰ ﻤـﺴﺘﻭﻯ . ﺍﻟﻰ ﺫﻴﺎﺩﺓ ﻏﻴﺭ ﻤﻌﻨﻭﻴﺔ 
 .  ﺍﻻﻴﺜﻠـﻰ ﺍﻟﻜﺤـﻭﻟﻰ   ﻭﻻﻴﻭﺠﺩ ﺍﺜﺭﻤﻌﻨﻭﻯ ﻟﻠﻤـﺴﺘﺨﻠﺹ 2 ﺒﻌﺩ ﺍﻻﺴﺒﻭﻉ ﺍﻟﺠﻠﺴﺭﻴﺩﺍﺕ ﺍﻟﺜﻼﺜﻴﺔ 
ﻭﺍﻟﺒﻭﻟﻰ ﺍﻴﺜﺎﻟﻴﻥ ﻜﻼﻴﻜﻭل ﺍﺩﻯ ﺍﻟـﻰ ﺫﻴـﺎﺩﺓ .4ﻭﻻﻴﻭﺠﺩ ﺍﺜﺭ ﻤﻌﻨﻭﻯ ﻟﻠﻤﺴﺘﺨﻠﺼﻴﻥ ﺒﻌﺩ ﺍﻻﺴﺒﻭﻉ 
 2 ﻓﻰ ﺍﻻﺴـﺒﻭﻉ  ﻤﻨﺨﻔﺽ ﺍﻟﻜﺜﺎﻓﻪ  ﻜﻭﻟﺴﺘﺭﻭل ﺍﻟﻼﻴﺒﻭﺒﺭﻭﺘﻴﻥﺴﺘﻭﻯ ﺍﻟﻜﻠﺴﺘﺭﻭل ﻭ ﻤﻌﻨﻭﻴﺔ ﻓﻰ ﻤ 
 ﺍﻟﻼﻴﺒـﻭﺒﺭﻭﺘﻴﻥ  ﻭﻴﻭﺩﻯ ﺍﻟﻰ ﺫﻴﺎﺩﺓ ﺭﻗﻤﻴﺎ ﻓﻰ ﻤﺴﺘﻭﻯ .4ﻭﻓﻰ ﻤﺴﺘﻭﻯ ﺍﻟﻜﻠﺴﺘﺭﻭل ﻓﻰ ﺍﻻﺴﺒﻭﻉ 
  .4 ﻓﻰ ﺍﻻﺴﺒﻭﻉ  ﻤﻨﺨﻔﺽ ﺍﻟﻜﺜﺎﻓﻪﻜﻭﻟﺴﺘﺭﻭل
ﻠـﻰ ﻓﻰ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺜﺎﻨﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻜﺤﻭﻟﻰ ﻟﻠﺠﻨﺯﺒﻴل ﻟﻡ ﻴﻅﻬﺭ ﺘﺎﺜﻴﺭ ﻤﻌﻨـﻭﻯ ﺍﺤـﺼﺎﺌﻴﺎ ﻋ 
ﻭﺍﻟﺫﻯ ﺨﻔﺽ ﻤـﺴﺘﻭﻯ  ﺍﻟﺴﻜﺭﻯ ﺍﻟﻜﻠﻴﺒﻥ ﻜﻼﻤﺎﻴﺩ  ﻤﺭﺽ ﻋﻼﺝﻤﺜل  ﻤﺴﺘﻭﻯ ﺍﻟﺠﻠﻜﻭﺯ ﻓﻰ ﺍﻟﺩﻡ 
  .ﺍﻟﺴﻜﺭ ﻓﻰ ﺍﻟﺩﻡ ﻤﻌﻨﻭﻴﺎ
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 16
ABBREVATION 
 
ACAT        Acyl-CoA cholesterol acyltransferase. 
ANOVA     Analysis of variance 
ATP           Adenosine triphosphate   
CHD          Coronary heart disease 
CNS           Central nervous system 
CoA           Coenzyme A 
COX-2      Cyclooxygenase-2 
DM            Diabetes mellitus 
G.T.T       Glucose Tolerance test 
HDL         High density lipoprotein  
HMG       3-hydroxy-3-methylglutaryl 
IDDM     Insulin –dependent diabetes mellitus 
IDL          Intermediate density lipoprotein 
IPP          Isopentenyl pyrophosphate. 
LCAT     Lecithin cholesterol acyl-transferase 
LDL        Low density lipoprotein  
NIDDM  Non-insulin dependent diabetes mellitus 
NO          Nitric oxide 
SAS        Statistical analysis of the data system 
TG         Triglycerides 
Vit          Vitamin  
VLDL    Very Low density lipoprotein 
WHO     World Health Organization  
PEG        Polyethylene glycol 
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INTRODUCTION 
Atherosclerosis is the principal contributor to the pathogenesis of 
myocardial and cerebral infarction. Elevated plasma concentration of 
cholesterol, especially in LDL, is recognized as leading to the 
development of atherosclerosis. On the other hand, there is convincing 
evidence that relaxation mediated by endothelium-derived nitric oxide 
(NO) is impaired in arteries from hypercholesterolemic and 
atherosclerotic animals (Shimokawa and Vanhoutte, 1989; Verbeuren et 
al., 1986). 
Biochemically cholesterol is of significance because it is precursor of 
large number of equally important steroids such as bile acids, 
adrenocortical hormones, sex hormones, vitamin D (Vit D), cardiac 
glycosides, sistosterols of plant kingdom and some alkaloids (Murray et 
al., 1999). 
 The   drugs used for lowering blood cholesterol generally have    
undesirable side effects. Hence, harmless lipid-controlling mediation 
would be a welcome development .Medicinal and aromatic plants are 
the important renewable source of drugs. In addition, WHO encourages 
the inclusion of medicinal plants in programmes of developing 
countries because of the great potential these plants represent in 
combating various diseases. Recently, the Sudan has produced certain 
drugs locally using important or native raw materials (Gabir, 2001). 
Ginger (Zingiber officinale) is used in folk medicine for relief of many 
ailments, especially nausea, motion sickness, and other gastrointestinal 
disorders (Langner et al., 1998). 
The objective of this study was to investigate the effect of ethanolic 
extract and petroleum ether extract of Zingiber officinale on level of 
plasma total cholesterol and its fractions (low density lipoproteins and 
high density lipoproteins cholesterol) and triglycerides in an induced 
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hyper-cholesterolemic Wistar albino rats and the hypoglycemic effect of 
Z.officinale ethanolic extract in an induced hyperglycemic Wistar albino 
rats. 
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CHAPTER ONE 
LITERATURE REVIEW 
1.1 Lipids: 
Lipids are heterogeneous group of compounds related more by their 
physical rather than by their chemical properties. They have the 
common property of being relatively insoluble in water and soluble in 
nonpolar solvents. Thus, the lipids include fats, oils, steroids, waxes and 
related compound. Lipids are important dietary constituents not only 
because of their high energy value but also because of the fat-soluble 
vitamins and the essential fatty acids contained in the fat of natural 
foods (Murray et al., 1999). 
In order to transport lipids between blood and different tissues, they are 
associated with protein to form water soluble complex. This protein 
fraction is synthesized in the liver and it is called 
“apolipoprotien”.Lipids play many roles in biological system, like 
carbohydrate they are an important source of energy. In addition they 
are essential component of membranes, they function as hormones, and 
they can also serve as padding and thermal insulator (Murray et al., 
1999). 
1.1.1 Cholesterol   
Cholesterol is an extremely important biological molecule that has roles 
in membrane structure as well as being a precursor for the synthesis of 
the steroid hormones and bile acids (Champe and Harvey, 1994).  Both 
dietary cholesterol and that synthesized denovo are transported through 
the circulation in lipoprotein particles,the same is true for cholesterol 
esters, the form of which cholesterol is stored in cells. The synthesis and 
utilization of cholesterol must be tightly regulated in order to prevent 
over –accumulation and abnormal deposition within the body, of 
particular importance clinically is the abnormal deposition of 
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cholesterol and cholesterol rich lipoprotein in the coronary arteries. 
Such deposition, eventually leads to atherosclerosis, which is a 
contributory factor in the disease of the coronary arteries. 
1.1.2 Biosynthesis of cholesterol 
The process has five major steps as it is shown in figure 1 (Michael, 
1996). 
1-acetyl-CoAs are converted to 3-hydroxy-3-methylglutaryl-CoA 
(HMG-CoA). 
2- HMG-CoA is converted to mevalonate 
3- Mevalonate is converted to the isoprene based molecule, isopentenyl 
pyrophosphate (IPP), with the concomitant loss of CO2 
4- IPP is converted to squalene 
5- Squalene is converted to cholesterol. 
1.1.3 Regulation of cholesterol synthesis: 
The cellular supply of cholesterol is maintained at a steady level by 
three distinct mechanisms. Regulation of HMG-COA reductase activity 
and level regulation of excess intracellular free cholesterol through the 
activity of acyl-CoA cholesterol acyltransferase (ACAT), and regulation 
of plasma cholesterol level via LDL receptor-mediated reverse 
transport. 
1.1.4 Types of cholesterol: 
1.1.4.1 High density lipoprotein (HDL): 
High density lipoprotein is one of the major classes of the plasma 
lipoproteins. It is a central player in the cholesterol economy of the 
body (good form of cholesterol), derived largely from the liver and on 
entering the circulation is found to be discoid in shape. The disc 
consists of phospholipids, cholesterol bilayer  associated with a number 
of apolipoprotien and the enzyme lecithin cholesterol acyl-transferase 
(LCAT) (Brian etal.,2001).In reverse cholesterol transport, HDL 
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attaches to the A-1receptors,causing translocation of cholesterol to the 
cell membrane, where it is taken up by HDL. A concentration gradient 
is maintained by the activity of LCAT, which allow cholesterol to be 
esterified and deposited in the core of HDL, then it taken up by the liver 
either directly, or after transport to VLDL,IDL or LDL via the 
cholesterol ester transfer protein(Robert et al.,1996). 
1.1.4.2 Low density lipoprotein (LDL): 
 Low density lipoprotein is called bad form of cholesterol; it is the 
major cholesterol-carrying lipoprotein in plasma. Most LDL-cholesterol 
appears to be formed from VLDL via IDL. These remnants are 
composed mainly of cholesterol ester and apo-B100 and it taken up by 
the liver (70%) and other tissues (30%) via the LDL. 
The number of LDL receptors on the cell surfaces is regulated by the 
cholesterol requirement for membrane, steroids hormone, or bile acids 
synthesis. Thus, influx of cholesterol down regulates the number of 
LDL receptors (Robert et al., 1996; Brian et al., 2001). 
1.1.5 Triglycerides: 
Triglycerides are esters of the alcohol glycerol and fatty acids. They are 
the main storage form of fatty acids. They represent the most important 
class of dietary fats which constitute more than 90% of the dietary 
lipids. These compounds also supply the body with the essential fatty 
acids required, for the provision of energy (Murray et al., 1999).A 
recent study showed that having a high level of triglycerides increase 
the chance of having attack (John,1995) indeed many people with a 
high levels of plasma triglyceride were found to have low level of HDL 
(Kelley,2002). 
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Fig (1) Cholesterol biosynthesis 
pathway 
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1.2 Development of atherosclerosis and coronary heart disease: 
1.2.1 Atherosclerosis: 
Atherosclerosis refers to the deposition of cholesterol and cholesterol 
ester of lipoproteins containing apo B-100 in the arterial wall which 
leads to the formation of plaque and result in endothelial damage and 
narrowing of the lumen. 
It remains dormant in the body for two or three decades without 
showing an outward symptom of its presence in the form of high blood 
pressure, heart disease and cerebral haemorrhage, eventually leading to 
coronary heart disease (Basavaraju and Jones, 1998). 
1.2.2 Coronary heart disease (CHD): 
Coronary heart disease refers to spectrum of clinical heart disorders 
resulting from inadequate blood flow to the heart muscle, compared to 
its needs. CHD is caused by atherosclerotic narrowing of coronary 
arteries. It has been demonstrated consistently, in epidemiological 
studies within and between populations, that there is a continuous 
increase in risk of death from CHD with increasing serum cholesterol. 
Major risk factor for CHD seems to be a high concentration of LDL-
cholesterol, which carries about 70% of the total circulating cholesterol 
.In contrast levels of HDL-cholesterol are thought to have a protective 
effect, and lower the risk of CHD (Griffin et al., 1998). 
1.3 Diabetes mellitus: 
Diabetes mellitus (DM) is a metabolic disorder affecting carbohydrate, 
fat and protein metabolism characterized by hyperglycemia. It requires 
life long treatment with drugs coupled with diet control and exercise. 
Most patients can be classified clinically as having either insulin –
dependent diabetes mellitus (IDDM or type I) or non-insulin dependent 
diabetes mellitus (NIDDM or Type II) and the Gestational diabetic 
mellitus when a pregnant women become diabetic at some stage during 
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pregnancy and there is other types of diabetes. Diabetes is one of the 
stress related disorder. Diabetic subjects are shown to have increased 
oxidative stress and decreased antioxidant levels (Jain et al., 1996; 
Feillet et al., 1999).The worldwide survey reported that the DM is 
affecting nearly 10% of the population (Siddharth, 2001). 
1.3.1 Drugs used for lowering blood cholesterol and treatment of 
diabetes mellitus: 
1.3.1.1 Drugs used for lowering blood cholesterol: 
Various medications can lower blood cholesterol levels. They may be 
prescribed individually or in combination with other drugs include: 
statins also known as HMG CoA reductase inhibitors (Atorvastatin), 
selective cholesterol absorption inhibitors (Ezetimibe),resins also 
known as bile acid sequestrant or bile acid-binding drugs 
(Colestipol),fibrates are fibric acid derivatives (Gemfibrozil) and niacin 
which is nicotinic acid (Niaspan) (American Heart Association, 2008). 
They do have side effects which include muscle and joint aches most 
common, nausea, diarrhea, constipation, and liver damage (Mayo, 
2008).                                                                                                                                      
Hence, harmless lipid-controlling mediation would be a welcome 
development .Medicinal and aromatic plants are the important 
renewable source of drugs. In addition, WHO encourages the inclusion 
of medicinal plants in programmes of developing countries because of 
the great potential these plants represent in combating various diseases 
(Gabir, 2001). 
1.3.1.2 Drugs used for treatment of diabetes mellitus: 
In modern medicine, the beneficial effects on glycemic levels are well 
documented. Insulin is the drug of choice in type – I diabetes and 
sulfonylureas are the drugs of choice in type II. Among sulfonylureas, 
tolbutamide is the drug of choice for geriatrics because of its short 
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duration of action and lower incidence of hypoglycaemia in early hours 
of night (Satyanarayana et al., 2005). 
The preventing activity of these drugs against progressive nature of 
diabetes and its micro and macrovascular complications was modest 
and not always effective.  
Insulin therapy affords effective glycemic control, yet its short comings 
such as ineffectiveness on oral administration, short shelf life; 
requirement of constant refrigeration, and in the event of excess dosage, 
fatal hypoglycemia limits its usage.  
Treatment with sulfonylureas, tolbutamide and biguanides is also 
associated with side effects (Rang and Dale, 1991). 
For various reasons in recent years, the popularity of complementary 
medicine has increased. Dietary measures and traditional plant therapies 
as prescribed by Ayurvedic and other indigenous systems of medicine 
were used commonly in India (Warier, 1995). 
Surveys conducted in Australia and US indicated that almost 48.5% and 
34% respondents had used at least one form of unconventional therapy 
including herbal medicine (Eisenberg et al., 1993). WHO (1980) has 
also recommended the evaluation of the plants effectiveness  and in 
conditions where we lack safe modern drugs (Chattopadhyay et al., 
1999).Since time immemorial, patients with diabetes mellitus have been 
treated orally by folklore with a variety of plant extracts. In the 
indigenous system of medicine (Ayurveda), a mention was made on 
good number of plants for the cure of diabetes or ‘Madhumeha’ and 
some of them have been experimentally evaluated and the active 
principles were isolated (Chopra et al., 1958; Prout, 1974). 
1.4 Medicinal plants: 
The current surge of interest in phototherapeutics has led to numerous 
studies on medicinal plants in many countries .This resulted into a large 
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volume of literature on the taxonomy, biology, chemistery and a 
recording of the claimed medicinal utility of each plant. However, the 
latter aspect, namely the established clinical value of plant medicines is 
still lagging behind in research .Very few plants have been evaluated in 
systemic manner as medicinal bases and these have largely come from 
far eastern countries (Toshiyasu et al.,1994; Yamahara et al.,1988;Chen 
et al.,1985).In the Sudan ,numerous plants or plant products are 
commonly used by rural and urban citizen for the treatment of a wide 
variety of condition ,often without prior research  to prove their claimed 
efficacy(Bakhiet 1995;Omer et al.,1992 and Ahmed,1988). 
1.4.1 Hypolipidemic plants: 
Numerous medicinal plants have shown hypolipidemic activity by 
various experimental assay methods. Several of these are available in 
commercial preparation, either as single extract or in combination 
products (Winston, 1999). 
1.4.1.1 Nigella sativa 
Nigella sativa seeds when fed to broiler chicks at a dose rate of 0.75% 
resulted in a significant reduction in serum total lipids concentration 
(Abdel Mageed,1999).Also Nigella sativa was shown to reduce serum 
cholesterol in human when was used for two week at a dose of 
2mg/day(Bamosa et al.,1997).In addition, Nigella sativa oil was 
reported to reduce serum total cholesterol and triglycerides when was 
given orally to rats for 4 weeks (El-Dakhakhny et al.,2000). 
1.4.1.2 Marsilea minuta: 
Feeding of Marsilea minuta leaf extract to gerbils was found to reduce 
serum cholesterol and triglycerides by 31 and 63%, receptively. Also 
liver cholesterol and triglycerides were lowered by 71 and 27% 
respectively (Malinow et al., 1980; Satoh et al., 1995). 
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1.4.1..3 Myristic fragrans: 
The ethanolic extract of Myristica fragrans given to induce 
hyperlipidaemic albino rabbits at a dose 500 mg/kg body weight daily 
for 60 days resulted in a reduction in total cholesterol of the heart and 
the liver (Alpana et al., 1996). 
1.4.1.4 Salvadora persica L: 
Salvadora persica L showed hypocholestrolaemic properties when it 
was given in rats diet at dose 500 mg/kg body weight for 15 and 30 
days, but triglycerides were unchanged (Galati et al., 1998). 
1.4.1..5 Vaccinium myrtillus: 
Oral administration of the hydro-alcoholic extract of Vaccinium 
myrtillus leaves significantly decrease plasma triglycerides and 
cholesterol levels (Cignarella et al., 1993). 
1.4.1.6 Turmeric root: 
Turmeric root contains curcumin and other essential oil.Curcumin 
increase the secretion of bile by stimulating the bile duct, and then helps 
to treat high cholesterol level (Soudamini et al., 1999). 
1.4.1.7 Gum arabic: 
Gum arabic showed a significant cholesterol lowering effect in rats 
when fermented (Moundras et al., 1994). 
1.4.1.8 Fruits and vegetables: 
Addition of fruits and vegetables to normal diet was found to reduce 
serum total cholesterol (Singh et al., 1992). 
1.4.1.9 Fibers: 
Soluble fibers have greater potential to alter serum lipid concentration 
(Glore et al.,1994).Generally, high fiber intake was found to be 
associated with lower serum cholesterol concentration (Anderson et 
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al.,1994).Also pectin was shown to reduce cholesterol and triglycerides 
in rats(Vigne,1987). 
1.4.1 Hypoglycemic plants: 
Recently, many experimental and clinical trials have been made to 
detect the hypoglycemic and anti –diabetic effects on many medicinal 
plants used in the medicine for treatment of diabetes mellitus.  
1.4.2.1 Zizyphus lotus: 
Earlier studies on the leave of Zizyphus lotus were carried out 
(Glombitza et al., 1994).They reported that Zizyphus lotus caused a 
significant reduction in fasting serum glucose, and improved glucose 
utilization in alloxan diabetic rabbits without affecting serum insulin 
and peptide levels. 
1.4.2.2 Zizyphus spina Christi: 
Streptozotocin induced diabetic and non a diabetic rats were given oral 
100 mg/kg dose of butanol fraction prepared from methanolic extract of 
Zizyphus spina Christi,or 10 mg/kg of christinin –A, the principle 
saponin glycoside contained in the butanol fraction, treatments were 
continued daily for period of 1 week or month, whereas no significant 
effects were observed in non diabetic (control rats), both the butanol 
fraction and christinin-A(long treatments)significantly reduced serum 
glucose levels, inhibited liver phosorylase and glucose-6 phosphates 
activities (Glombitza et al., 1994) 
1.4.2.3 Jumibers communis berries: 
Jumibers communis berries showed a significant reduction of  blood 
glucose levels in studies on intestinal glucose absorption ,peripheral  
glucose consumption and pancreatic action indicated that the 
hypoglycemic activity of Jumibers communis berries is due to an 
increased consumption of peripheral glucose and or increase  glucose –
induced insulin secretion (Wasfi, 1994). 
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1.4.2.4 Allium sativum: 
Feeding a diet containing 12.5% body weight Allium sativum (garlic), to 
alloxan-induced diabetic rats for 15 days showed a significant reduction 
of blood glucose levels (Jelodar et al., 2005) 
1.4.2.5 Piminella anisum: 
Feeding Piminella anisum 15% in diet to diabetic and normal rats for 3 
weeks showed a significant reduction of blood glucose levels (Fath-
Elrhman, 2006). 
1.4.2.6 Nymphaea stellata: 
The ethanolic extract of leaves of Nymphaea stellata given by oral route 
to diabetic rats at dose of 100 and 200 mg/kg/day for seven days 
reduced significantly by 31.6 and 42.6 % the plasma glucose level 
increased by intraperitoneal injection of 120 mg/day of alloxan 
(Dhanabal, 2007). 
1.5 Zingiber officinale: 
1.5.1 Taxonomy of Zingiber officinle 
Kingdom:      Plantae 
Division:        Magnoliophyta 
Class     :        Liliopsida 
Order   :        Zingiberales 
Family:          Zingiberaceae 
Genus:           Zingiber 
Species:         Z.officinale ( )ﻞﻴﺑﺰﻨﺠﻟا  (Ginger). 
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1.5.2 Definition: 
Rhizoma Zingiberis is the dried rhizome of Zingiber officinale Roscoe 
(Zingiberaceae) (Standard of ASEAN Herbal Medicine, 1993; The 
Japanese Pharmacopoeia XIII, 1996). 
 
 
1.5.3 General appearance: 
Ginger occurs in horizontal, laterally flattened, irregularly branching 
pieces; 3– 16 cm long, 3–4 cm wide, up to 2 cm thick; sometimes split 
longitudinally; pale yellowish buff or light brown externally. 
Longitudinally striated, somewhat fibrous; branches known as "fingers" 
arise obliquely from the rhizomes, are flattish, obovate, short, about 1–3 
cm long; fracture, short and starchy with projecting fibers. Internally, 
yellowish brown, showing a yellow endodermis separating the narrow 
cortex from the wide stele, and numerous scattered fibro vascular 
bundles, abundant. Scattered oleoresin cells with yellow contents and 
numerous larger grayish points, vascular bundles, scattered on the 
whole surface (Standard of ASEAN Herbal Medicine, 1993; The 
Japanese Pharmacopoeia XIII., 1996). 
1.5.4 Geographical distribution: 
The plant is probably native to south-east Asia and is cultivated in the 
tropical regions in both the eastern and western hemispheres. It is 
commercially grown in Africa, China, India, and Jamaica; India is the 
world's largest producer (African Pharmacopoeia, 1985; Bisset et al., 
1994). 
1.5.5 Chemical composition: 
Z.officinale  nutritional value per 100 g (3.5 oz) are energy 20 kcal   80 
kJ, carbohydrates 17.77g, sugars 1.7g,dietary fiber 2g,fat 0.75,protein 
1.82g,thiamine(Vit B1)0.025 (2%), riboflavin(Vit B2) 0.034 mg 
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(2%) ,niacin(Vit B3)  0.75 mg  (5%),pantothenic acid (B5)  0.203 
mg (4%), vitamin B6 0.16 mg ( 12%),folate (Vit. B9)  11 
µg (3%),vitamin C 5mg(8%), calcium16mg (2%),iron 0.6 mg(5%),            
 magnesium 43mg(12%), phosphorus34mg(5%),potassium 415mg(9%),
and zinc  0.34 mg(3%). 
Zingiber officinale Roscoe contains not less than   2% v/w of volatile oil 
(Standard of ASEAN Herbal Medicine, 1993), as determined by the 
method described in WHO guidelines (Quality Control Methods for 
Medicinal Plant Materials, 1998). 
Qualitative analysis by thin-layer chromatography; qualitative and 
quantitative gas chromatography and high performance liquid 
chromatography analyses of ginger oils showed the presence of 
gingerols,shogaols,α-zingiberene,β-bisabolene,β-
sesquiphellandrene,andar-curcumene(Yoshikawa,1993). Representative 
structures of zingiberene, gingerols and shogaols are illustrated in figure 
4. 
1.5.6 Major chemical constituents: 
The rhizome contains 1–4% essential oil and an oleoresin. The 
composition of the essential oil varies as a function of geographical 
origin, but the chief constituent sesquiterpene hydrocarbons 
(responsible for the aroma) seem to remain constant. These compounds 
include (-)-zingiberene, (+)-ar-curcumene, (-)-β- sesquiphellandrene, 
and β-bisabolene. Monoterpene aldehydes and alcohols are also present. 
The constituents responsible for the pungent taste of the drug and 
possibly part of its anti-emetic properties have been identified as 1-(3'- 
methoxy-4'-hydroxyphenyl)-5-hydroxyalkan-3-ones, known as [3–6]-, 
[8]-, [10]-, and [12]-gingerols (having a side-chain with 7–10, 12, 14, or 
16 carbon atoms, respectively) and their corresponding dehydration 
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products, which are known as shogaols ( Awang, 1982;Yoshikawa  , 
1993).  
1.5.6 A current look at ginger use: 
Ginger (Zingiber officinale) is used in folk medicine for relief of many 
ailments, especially nausea, motion sickness, and other gastrointestinal 
disorders (Langner et al., 1998). 
 
1.5.6.1 Antioxidant effect:  
The antioxidant properties of ginger have been shown in various 
investigations. In one study, the oxidative stress induced by malathion 
(a pesticide) into rats was overcome by introducing ginger into the rats' 
diets (Ahmed et al., 2000). 
 The antioxidant activity of Zingiber officinale was shown to be as 
effective as vitamin C in lowering lipid peroxidation in rats by 
influencing the enzymatic blood level of superoxide dismutase, catalase, 
and glutathione peroxidase (Ahmed et al., 2000).  
 The lipid peroxidation lowering associated with ginger consumption 
was also demonstrated in apolipoprotein E-deficient mice (i.e., mice 
that are prone to develop atherosclerosis). Mice that consumed ginger 
(250 mcg of extract/day) in their drinking water showed a significant 
reduction in their basal concentration of LDL-associated lipid peroxides 
(Bianca et al., 2000). 
1.5.6.2 Anti-tumor effect:  
Ginger is listed among the herbs possessing the highest antitumor 
activities. The observed evidence from in vitro experiments warrants 
further investigations into the potential anti-tumor activity of ginger.  
This antitumor activity was shown to be related to its vanilloids, [6]-
gingerol and [6]-paradol. Both compounds were shown to block the 
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epidermal growth factor responsible for cell transformation, thus 
inhibiting cellular proliferation (Bode et al., 2001; Surh, 1999). 
Ginger may also produce its antitumor effect by inducing "programmed 
cell death," also known as apoptosis, in cancer cells (Thatte et al., 
2000). 
 In one study, the cytotoxic effect of [6]-gingerol and [6]-paradol was 
associated with the induction of apoptosis in human promyelocytic 
leukemia cells (Lee and Surh, 1998).  
A third mechanism of ginger's antitumor protection is its modification 
to the carcinogen-metabolizing enzymes in the liver. Both glutathione 
S-transferase and aryl hydrocarbon hydroxylase activity in the liver 
were elevated following administration of ginger oil to mice for 14 
consecutive days (Banerjee et al., 1994). The application of [6]-gingerol 
to the shaven backs of mice prior to applying cancer-promoting agents 
significantly inhibited skin cancer formation (Park et al., 1998). 
1.5.6.3 Anti-inflammatory effect: 
 The anti-inflammatory effect of [6]-gingerol was studied in a mouse 
model challenged with a phorbol ester. The phenolic compound was 
capable of suppressing the inflammatory effect of TPA (Park et al., 
1998). Male Sprague-Dawley rats with severe arthritis were treated with 
ginger oil (33 mg/kg per os) for 26 days. The treatment resulted in a 
significant reduction in joint swelling (Sharma et al., 1994). The 
oleoresin constituents in Zingiber officinale, as well as the phenolic 
substances paradol and shogaol, were shown to possess an inhibitory 
action on cyclooxygenase-2 (COX-2) enzymatic activity, a mechanism 
important in controlling the inflammatory process (Tjendraputra et al., 
2001).  
Another mechanism of ginger as an anti-inflammatory herb was 
proposed to relate to inhibitory effects on leukotriene and prostaglandin 
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biosynthesis, both of which are important in the inflammatory process 
(Srivastava and Mustafa, 1992; Kiuchi et al., 1992). In a randomized, 
placebo-controlled, double-blind, crossover study, a ginger extract was 
compared to ibuprofen in patients with osteoarthritis of the hip and 
knee. The ibuprofen showed a significant reduction in pain, ginger 
extract was not significantly different from a placebo when the study 
was terminated (Bliddal et al., 2000). It appears that issue of using 
ginger for osteoarthritis or as anti-inflammatory is not supported in 
human clinical trials. 
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Figure 2: Representative structures of zingiberene, gingerols and 
shogaols. 
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1.5.6.4 Nausea and emesis: 
Some studies (randomized, double-blind, placebo-controlled) have 
shown that the use of ginger to prevent postoperative nausea and 
vomiting in women who have undergone gynecological diagnostic lapa-
roscopy was not effective (Visalyaputra et al., 1998; Arfeen et al., 
1995).  
However, another randomized, placebo-controlled, double-blind study 
involving 60 women who had undergone gynecological surgeries shown 
that the effect of ginger on nausea was similar to that of 
metoclopramide. Both ginger and metoclopramide significantly lowered 
the incidence of nausea after surgery compared to the placebo group 
(Bone et al. ,1990).In another study, similar results were found 
involving  with a larger group of patients (120 women) undergoing the 
same surgical procedure(Phillips (a) et al.,1993). The antiemetic effect 
of ginger was investigated in rats receiving cisplatin. Ginger extracts or 
ginger juice given to rats reversed the effect of the cisplatin-induced 
delay in gastric emptying (Sharma et al., 1998). However, no effect 
from ginger (1 g) was observed in 16 healthy volunteers on gastric 
emptying (Phillips (b) et al., 1993).  
 Evidence from these studies suggests that the usefulness of ginger to 
alleviate nausea and vomiting is still debatable.    
1.5.6.5 Motion sickness: 
The use of ginger root for preventing seasickness and motion sickness 
was investigated in several studies. In one attempt to prevent 
seasickness, ginger root was compared to six other medications in a 
randomized, double-blind study of 1,741 tourist volunteers 
(observations were obtained from 85.5% of the participants) (Schmid et 
al., 1994).Ginger root was found to be as effective as five out of the six 
medications, and superior to scopolamine transdermal therapeutic 
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system in preventing seasickness. This anti-motion effect of ginger was 
not shown to be related to its CNS effects (Holtmann et al., 1989).  But 
this anti-motion effect is possibly due to anticholinergic and 
antihistaminic actions (Qian and Liu, 1992). In a separate study, the 
anti-motion sickness effect of ginger compared to scopolamine or a 
placebo was tested on 28 subjects. Ginger showed no activity against 
motion sickness in doses as high as 1,000 mg given orally. In contrast, 
scopolamine (0.6 mg per os) provided significant protection against 
motion sickness when compared to the control group (Stewart et al., 
1991).  
 Thus, the use of ginger for the prevention of seasickness remains 
controversial.  
1.5.6.6 Precautions: 
Although it is not widely recognized by the general public, treatment 
with herbs can interfere with the action of many drugs, resulting in 
potentially risky consequences. Ginger can enhance the anticoagulant 
effect of warfarin, leading to an increased risk of bleeding (Argento et 
al., 2000; Miller, 1998). Platelet aggregation in 20 healthy male 
volunteers was enhanced by the consumption of 100 g of butter per day 
for one week. Concomitant administration of dry ginger (5 g) 
significantly inhibited platelet aggregation (Verma et al., 1993). In a rat 
model, however, this interaction between ginger and warfarin was 
absent (Weidner et al., 2000).  Ginger use is also contraindicated if the 
patient suffers from gallstones, due to ginger's cholagogue effect (i.e., it 
promotes the flow of bile into the intestine) (Brinker, 1998). 
1.5.6.7 The Use of ginger in pregnancy: 
Perhaps ginger is most popular for its antinausea and antiemetic effects 
in pregnancy. Up to 85% of pregnant women experience nausea in early 
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pregnancy, and some 50% of those with nausea experience vomiting as 
well (Young, 2000). 
In two major trial databases on the use of antiemetic agents during 
pregnancy, ginger was found to provide some relief from nausea and 
vomiting; however, no strong support for its use for this condition was 
recommended(Young , 2000).A randomized, placebo-controlled, 
double-blind study was carried out on 70 women in the first 17-week 
period of gestation. The women were given either a placebo or an oral 
ginger formula (1 g/day) for four days. Pregnant women recorded the 
incidents of nausea and vomiting during the treatment and those that 
had occurred one day prior to the start of treatment. Those who received 
ginger reported a significantly higher reduction in the number of 
episodes of nausea and vomiting than those who took a placebo 
formulation (Vutyavanich et al., 2001). Similar results were observed in 
another randomized, placebo-controlled, double-blind, crossover study. 
A significantly greater reduction in the symptoms of hyperemesis 
gravidarum (pernicious vomiting during pregnancy) was observed with 
ginger treatment (1 g/day of powdered ginger root) than was seen in the 
control group (Fischer-Rasmussen et al., 1991).  
1.5.6.8 Safety of ginger use during pregnancy: 
Although ginger is commonly used for morning sickness during 
pregnancy, no major safety study on its use has been reported .Scattered 
studies in animals, however, pointed to ginger's potential harmful 
effects if used during pregnancy and caution against its use (Wilkinson, 
2000).  Ginger tea was given to pregnant Sprague-Dawley rats for 20 
days from the day of gestation. The rate of spontaneous loss of fetuses 
was double in the ginger group than in a control group. However, the 
surviving fetuses were heavier and more developed in the ginger group 
than those in the control group (Wilkinson, 2000).The potential loss of 
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fetuses after ginger use was also reported in another communication 
using experimental animal models (Farnsworth et al., 1975).  This 
harmful effect on the fetus is perhaps linked to blood-thinning 
properties of ginger, which may facilitate and enhance blood flow. 
However, other reported experiments failed to show any harmful effect 
on the developing fetus in Wistar SPF rats receiving ginger extracts 
(Weidner and Sigwart , 2001). In particular, ginger is used for morning 
sickness during the first trimester of pregnancy. However, a recent 
literature search on ginger concluded that its use during pregnancy has 
not been shown to be absolutely safe (Wilkinson, 2000). 
 Because of the uncertainty concerning the safety of ginger use, 
pharmacists should advise women not to include ginger in a self-
treatment program before first consulting with their 
obstetrician/gynecologists. Until further information on its safety is 
known, the use of ginger during pregnancy is not recommended. It 
should be used only after consultation with a healthcare provider.  
1.5.6.9 Activities and medicinal uses of ginger: 
 Ginger rhizomes are also widely used in foods for their medicinal 
benefits, especially in Asia. For example, chine women consume ginger 
vinegar soup following delivery (Chan et al., 2000).According to 
tradition; the soup provides iron and calcium to the new mother. 
Ginger (Zingiber officinale Roscoe) is one of the world’s best known 
spices, and it has also been universally used throughout history for its 
health benefits. The dried extract of ginger contains monoterpenes and 
sesquiterpenes. The main antioxidant active principles in ginger are the 
gingerols and shogaols and some related phenolic ketone derivatives 
.Ginger extract possesses antioxidative characteristics, since it can 
scavenge superoxide anion and hydroxyl radicals (Cao et al.,1993 
;Krishnakantha and Lokesh ,1993 ; Reddy and Lokesh ,1992 ).Gingerol 
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from ginger inhibited, at high concentrations, ascorbate/ferrous complex 
induced lipid peroxidation in rat liver microsomes (Reddy and Lokesh, 
1992 ). Gingerol isolated from Zingiber was shown to inhibit platelet 
function due to inhibition of thromboxane formation (Guh et al., 1995 ), 
and ginger was also suggested to interfere with inflammation processes 
(Ozaki et al., 1991 ). Furthermore, ginger acts as a hypolipidemic agent 
in cholesterol-fed rabbits (Bhandari et al., 1998; Sharma et al., 1996 ). 
Feeding rats ginger significantly elevated the activity of hepatic 
cholesterol-7-hydroxylase, the rate-limiting enzyme in bile acids 
biosynthesis, thereby stimulating cholesterol conversion to bile acids, 
resulting in elimination of cholesterol from the body (Srinivasan and 
Sambaiah, 1991 ).  
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Figure (3) Zingiber officinale 
 
 
 
 
 
Figure (4) Sketch of ginger plant 
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CHAPTER TWO 
MATERIALS AND METHODS 
This work had been carried out in the department of Pharmacology in 
Medicinal and Aromatic Plants Institute (MAPRI), National Center for 
Research, Khartoum and Research laboratory Unit, Khartoum Teaching 
Hospital. 
2.1 Materials: 
2.1.1 Experimental animals: 
Wistar albino rats of either sex were used in the present experiments 
weighing between 70 – 165g. The rats were housed in cages in air 
conditioned room under 12-h light: dark cycle. All the rats were initially 
fed standard diet for at least 7 days to acclimatize to the house. They 
were divided into five and three groups of six rats each for the first   and 
the second experiment respectively.  
2.1.2 Plant material: 
Zingiber Officinale dried rhizome were collected from local market and 
authenticated by botanists in herbarium of Medicinal and Aromatic 
Plants Research Institute, Khartoum. 
2.1.2.1 Preparation of the petroleum ether and ethanolic extracts:   
Five hundred grams of dried powder of Zingiber officinale was 
extracted with petroleum ether (40 – 60) 0C and ethanol (80%) using 
Soxhelt apparatus for about six hours for petroleum ether and 16 hours 
for ethanol. Extracts were then evaporated under reduced pressure using 
Rotavapour apparatus. Extracts were allowed to dry completely and 
then kept in refrigerator till use. The two extracts were dissolved in the 
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suitable vehicle. The ethanolic extract was dissolved in distilled water 
and the petroleum ether extract in polyethylene glycol (PEG).  
2.1.3 Feeding program: 
A basal diet which fulfilled rat’s requirements was obtained from the 
Medicinal and Aromatic Plants Research Institute Khartoum. The diet 
was composed of meat (725g) and flour (240g) plus salt (1g).  
Each group was kept in a cage and was supplied with feed and water. 
2.1.3.1 First experiment: 
Cholesterol powder was added to the basal diet of rats to induce 
hypercholesterolemia   
The five group of the first experiment were fed as follows: 
Groups A, B, C and D: received basal diet +1% cholesterol 
Group E: received basal diet. 
2.1.3.2 Second experiment: 
 All groups (A, B and C) in the second experiment received basal diet. 
2.1.4 Experimental work: 
2.1.4.1 Experimental design: 
2.1.4.1.1 First experiment: 
The animals were divided into five groups, A, B, C, D and E. 
Group A: 
The ethanolic extract was daily administered orally to group A rats at a 
dose of 200 mg/kg body weight (Bhandari et al., 2005). 
Group B: 
The petroleum ether extract was administered orally to group B rats at a 
dose of 200mg/kg body weight (Bhandari et al., 2005). 
Group C: 
The polyethylene glycol was daily administered orally to group C at a 
dose of 200 mg/kg body weight and kept as PEG control group 
(Bhandari et al., 2005). 
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Group D: 
Group D rats were kept as cholesterol and basal diet fed control group. 
Group E: 
The rats of group E were fed basal diet only and were kept as untreated 
control group. 
2.1.4.1.2 Second experiment: 
The animals were divided into three groups, A, B, C.  
Group A rats received orally distilled water after overnight (18h) fast 
and kept as control. 
 Group B rats received orally ethanolic extract of Zingiber officinale 
after overnight (18h) and kept fast as treated group. 
Group C rats received orally Glibenclamide (Diabetes mellitus drug) 
and kept as diabetes mellitus drug treated control group. 
2.1.5 Instruments: 
The instruments used in the experimentation include: 
Centrifuge. 
Pipettes. 
Heparinized capillary tubes. 
Plain vial. 
Heparin vial. 
The Roch diagnostic/Hitachi 92 analyzer. 
Fluorinated tubes. 
2.1.6 Chemicals: 
Cholesterol   powder. 
Lithium heparin. 
Polyethylene glycol. 
Glucose 50% solution. 
Halothane. 
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2.1.7 Experimental procedure: 
2.1.7.1 First experiment: 
At two weeks and after 4 weeks, and after an overnight(18h) fast the 
blood samples were drawn from the orbital plexus of all groups  by 
means of heparinized capillary glass tubes  under inhalation anathesia 
using halothane according to the method of khanna et al. (1993).Blood 
was collected in lithium heparin to separate the plasma. After 10 
minutes of centrifugation of blood at 500 rpm, supernatant plasma were 
immediately separated and frozen at -20 0C until it was analyzed for 
plasma total cholesterol, LDL-cholesterol, HDL-cholesterol and 
triglycerides. 
2.1.7.2 Second experiment: 
One to two ml of blood were drawn by capillary glass tubes in 
fluorinated test tubes from the orbital plexus of rats of the three groups, 
under inhalation anathesia using halothane according to khanna et al 
(1993).The collected blood was centrifuged at 500 rpm for 10 minutes 
to separate plasma .The plasma was kept at -20Co  until it was used to 
estimate glucose.  
After overnight fasting (14h) the level of plasma glucose was 
determined at 0h, and then all rats were injected intraperitonially by 
50% glucose solution at dose of 2g/kg body weight. 
Immediately after injection, distilled water was administered orally to 
group A, the Zingiber officinale ethanolic extract was administered 
orally at a dose of 200 mg/kg body weight to group B and group C was 
given orally a dose of 10 mg/kg body weight Glibenclamide.   
Plasma glucose level of all groups was then monitored 1h, 2 h, and 4 h 
after glucose injection. 
 
 
 46
2.2 Analytical methods: 
All plasma parameters were measured by using fully automated 
apparatus The Roch Diagnostic Hitachi 902 analyzer in Research and 
Laboratory Unit, Khartoum Teaching Hospital. 
2.2.1 The Roch Diagnostic/Hitachi 902 analyzer: 
It is an analyzer which used to report results on various body fluid 
samples for a wide range of analytic. It is fully automated, 
computerized and performs potentiometric and photometric assays. 
It consists of photometric measuring system, analytical processing unit, 
screen and printer. 
The analyzer characteristics include: 200 photometric tests per hour and 
refrigerated storage for 40 reagents containers. 
2.2.2 Determination of cholesterol: 
The cholesterol concentration was estimated by an enzymatic method 
which measures the total cholesterol concentration in the serum ,plasma 
or heparinzed blood as described by Richmond (1973). 
Principle 
Esterified cholesterol and free cholesterol in sample originate, by means 
of the coupled reactions described below:- 
                                                  Cholesterol esterase 
Cholesterol ester + H2O                                                                    cholesterol + 
fatty acid. 
                                                            Cholesterol oxidase 
Cholesterol + ½ O2+ H2O                                                            cholesterol + 
H2O2. 
 
                                                                    Peroxidase 
2H2O2 + 4-Aminoantipyrine + Phenol                                 Quinoeimine (pink 
color) +4H2O. 
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The intensity of pink color of quinoeimine is directly proportional to 
cholesterol concentration when measured at wave length 550 nm. 
The absorbance of the standard and samples was measured at wave 
length 550 nm.  
Reagents: 
• Good’s buffer pH (6 -7). 
• Phenol. 
• 4-aminoantipyrine. 
• Peroxidase. 
• Cholesterol esterase. 
• Cholesterol oxidase. 
• Sodium cholate. 
Procedure: 
Procedure is described in (2.2.7). 
 2.2.3 Determination of plasma high density lipoprotein (HDL): 
Very low density lipoprotein (VLDL) and low density lipoprotein 
(LDL) in the sample are precipitated with phosphotungsate and 
magnesium ions. The supernatant contains high-density lipoproteins 
(HDL).The HDL-cholesterol is then spectrophotometerically measured 
by means of the coupled of reactions described below (Grave, 1979; 
Burstein et al., 1980). 
Principle: 
It is a direct method consisting of two steps: 
1. Elimination of chylomicron, VLDL and LDL-cholesterol by 
cholesterol estrase, cholesterol oxidase and subsequently cholesterol 
catalase. 
                                                 Cholesterol esterase                                   
Cholesterol ester                                                                      cholesterol + fatty 
acid. 
 48
 
                                                      Cholesterol oxidase 
Cholesterol +   O2                                                                    cholesterol + H2O2. 
                                                
                                                         Catalase 
2H2O2                                                                                        2H2O.       +   O2          
                                                                                                                                                                                      
2. Specific measurement of the release of HDL-cholesterol, after the 
release of HDL-cholesterol by detergent in reagent (2).  
2H2O2 + 4-Aminoantipyrine + N-(2-hydroxy-3-sultopropyl)-3,5-
dimethoxyaniline                  Peroxidase                            
Quinoeimine (pink color) + 4H2O.  
The intensity of quinineimine dye produced is directly proportional to 
the cholesterol concentration when measured at 550nm.The absorbance 
of the samples and standard was measured at wave length 550 nm.  
Reagents: 
Reagent (1) consists of: 
• Good’s buffer (pH6.6). 
• Ascorbic oxidase. 
• Catalase. 
• Cholesterol oxidase. 
• Cholesterol esterase. 
• Surfactants. 
Reagent (2) consists of: 
• Good’s buffer (pH 7) 
• Sodium azide. 
• Peroxides. 
•  
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Procedure: 
Procedure is described in (2.2.7) 
2.2.4 Determination of plasma low density Lipoprotein (LDL): 
Low density lipoprotein (LDL) in the sample is precipitated with 
polyvinyl sulphate.Their concentration is calculated from difference 
between the serum total cholesterol in the supernatant after 
centrifugation. The cholesterol is spectrophotometerically measured by 
means of the coupled reactions described below (Assmann et al., 1984).  
Principle: 
In this method LDL-cholesterol is selectively protected from lipoprotein 
lipase by protecting reagent (R1), then in the second step LDL-
cholesterol is released and selectively determined by releasing reagent 
(R2). 
                                                 Cholesterol esterase 
Cholesterol ester + H2O                                                                 cholesterol + fatty 
acid. 
                                                      
                                                        Cholesterol oxidase 
Cholesterol + ½ O2+ H2O                                                         cholesterol + H2O2. 
                                                                    Peroxidase 
2H2O2+ 4-Aminoantipyrine + Phenol                             Quinoeimine (blue color 
complex) +4H2O.  
 
The intensity of blue color complex color of quinoeimine is directly 
proportional to cholesterol concentration when measured at wave length 
550 nm. The samples and standard absorbance was measured at wave 
length 550 nm.  
Reagents: 
Reagent (1) was consist of: 
• Good’s buffer pH (6 .8). 
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• Cholesterol esterase. 
• Cholesterol oxidase. 
• Catalase 
Reagent (2) was consist of: 
• Good’s buffer (7.0) pH. 
• 4-aminoantipyrine. 
• Peroxidase. 
• Sodium azide. 
Procedure: 
Procedure is described in (2.2.7). 
2.2.5 Determination of plasma triglycerides: 
Triglyceride level in plasma was measured by an enzymatic method in 
which triglyceride are enzymatically hydrolyzed to glycerol as reported 
by Richmond (1973).  
Principle: 
Plasma triglycerides were determined after enzymatic splitting with 
lipoprotein lipase; the indicator is quinoneimine which is generated 
from 4-aminoantipyirne and 4-chlorophenol by hydrogen peroxide 
under the catalytic action of peroxidase. 
                                        Lipoprotein   Lipase  
Triglycerides                                                                               glycerol + fatty 
acid. 
                                          Glycerol kinase  
Glycerol + ATP                                                                         glycerol-3-phosphate 
+ ADP. 
                                               G-3-p-oxidase 
Glycerol-3-phosphate + O2                                                            Dihydroxyacetone-
p+H2O2 
 4-aminoantipyrine+4-cholrophenol+2H2O                    Peroxidase          Quinoneimine 
(blue color) + 4H2O +HCL.  
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The intensity of blue color of quinoeimine is directly proportional to 
cholesterol concentration when measured at wave length 550 nm.  
The absorbance of the samples and standard was measured at wave 
length 550 nm. 
Reagents: 
• ATP. 
• Good’s buffer (pH7.2). 
• 4-chorophenol. 
• Magnesium chloride. 
• Peroxidase. 
• Glycerol kinase. 
• Glycerol-3-phasphate oxidase. 
• Lipoprotein lipase. 
• 4-aminoantipyrine. 
Procedure: 
Procedure is described in (2.2.7) 
2.2.6 Determination of Glucose: 
Glucose concentration in the plasma was determined by enzymatic 
method as described by Barham and Trinder(1972). 
Principle: 
In the presence of glucose oxidase, glucose is oxidized to gluconic acid 
and hydrogen peroxide. Hydrogen peroxide reacts, in the presence of 
peroxidase, with phenol and 4-aminophenazone to form aquinoneimine 
dye. The intensity of the pink color formed is proportional to the 
glucose concentration. 
Glucose+O2                                       glucose oxidase                                     gluconic 
acid+H2O2 
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2H2O2+4-aminophenaone+Phen        peroxidas                                 
Quinoneimine+4H2O.  
The intensity of pink color of quinoeimine is directly proportional to 
glucose concentration when measured at wave length 490 nm.  
The absorbance of the   samples and standard was measured at wave 
length 490 nm. 
Reagent:  
• Phosphate buffer (pH7.5). 
• Phenol. 
• 4-aminoanipyrine. 
• Glucose oxidase. 
• Peroxidase. 
Procedure: 
Procedure is described in (2.2.7) 
2.2.7 Procedure:   
For the determination of each parameter, 0.5 ml o the plasma was put in 
Hitachi sample cups. 
The sample cups were entered in specific place and registered in the 
screen .Thereafter, the machine was put on and the results were printed 
in ten minutes. 
2.3 Statistical analysis: 
The data were subjected to completely randomized design. Analysis of 
variance (ANOVA) and mean separation were conducted to test 
significant differences of groups, according to Gomez and Gomex 
(1984) with the aid of SAS computer programme (SAS, 1982). 
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CHAPTER THREE 
RESULTS 
3.1 The effect of ethanolic and petroleum ether extracts of Zingiber 
officinale on plasma total cholesterol level in an induced 
hypercholesterolemic Wistar albino rats:- 
The levels of plasma cholesterol levels of groups A, B, C, D and E at 
two weeks and after 4 weeks are presented in Tables 1 and 2 and Fig 5 
and 6. 
There was a significant increase (P≤0.05) in plasma total cholesterol 
level in all cholesterol fed rats groups (A, B, C, D) when compared with 
the control group (group E) at two weeks and after 4 weeks. 
At two weeks there was numerical increase in plasma cholesterol in 
group A and B when compared to cholesterol fed control group D. 
However, the plasma cholesterol level in  PEG treated (group C) was 
significantly higher (P ≤ 0.05) when compared to cholesterol fed control 
group D. 
After 4 weeks, there was no significant   difference in plasma 
cholesterol level in the Z. officinale treated group (A,B) and also PEG 
treated (group C) when compared to cholesterol fed control group D. 
However, the plasma cholesterol level of group C (275.5) was 
numerical higher than group A (193.5), B (221.7) and D (208.0).  
3.2: The effect of ethanolic and petroleum ether extracts of Z. officinale 
on plasma high density lipoprotein level in an induced 
hypercholesterolemic Wistar albino rats:- 
The plasma HDL-cholesterol levels of group A, B, C, D and E are 
presented in Table 1 and 2 and Fig 7 and 8. 
 The HDL-cholesterol levels in all groups (A, B, C, D) are not 
significantly different (p ≤ 0.05) when compared to non cholesterol fed 
control (group E) at two and after 4 weeks. 
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However at week 2, HDL plasma level in group B (47.6) was 
numerically higher when compared with group A (37.1), group D (39.6) 
and the non cholesterol fed control group E (39.4).   
3.3 The effect of ethanolic and petroleum ether extracts of Z. officinale 
on plasma low density lipoprotein level in an induced 
hypercholesterolemic Wistar albino rats:- 
The plasma LDL-cholesterol levels of group A, B, C, D and E are 
presented in Table 1 and 2 and Fig 9 and 10. 
The levels of LDL-cholesterol were significantly (p ≤ 0.05) higher  in 
all cholesterol fed groups when compared to non cholesterol fed control 
(Group E) at two weeks and after 4 weeks. 
At week 2, the LDL plasma level of Z.officinale treated group (A,B) 
were numerically higher than cholesterol fed control group (D) while 
PEG treated group(C) was significantly higher than cholesterol fed 
group (D).  At week 4, the plasma LDL level of rats of group A was 
significantly lower (P≤ 0.05) than LDL level of group B and C and was 
numerical lower than LDL level of group D (125.9 vs. 157.7) .While 
plasma LDL level of petroleum ether extract (group B) and PEG (group 
C) were numerically higher than cholesterol fed control (group D). 
3.4 The effect of ethanolic and petroleum ether extracts of Z. officinale 
on plasma triglycerides level in an induced hypercholesterolemic Wistar 
albino rats:- 
The plasma triglycerides levels of group A, B, C, D and E are presented 
in Table 1 and 2 and Fig 11 and 12.  
The triglycerides levels in groups A ethanolic group and C PEG group 
were significantly lower (p ≤ 0.05) when compared to groups E (non 
cholesterol fed) and B (petroleum ether group) at week two. 
 The triglycerides levels in groups A, B, C and D were not significantly 
different (p ≤0.05) when compared to control group (E) after 4 weeks. 
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However, at week 4 the plasma triglyceride level of control group E 
(77.7) was numerically higher than the level of A (66.3), B (66.2), C 
(57.3) and D (57.3). 
The polyethylene glycol at week 2 had no significant effect on plasma 
triglycerides and HDL level in an induced hypercholesterolemic Wistar 
albino rats but it increased significantly cholesterol and LDL plasma 
level (p ≤ 0.05).However, after 4 weeks, PEG increased numerically 
cholesterol (275.5 vs 208.0) and LDL (229.3 vs 157.7) plasma level and 
had no effect on HDL and triglyceride level.  
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Table (1): The effect of Z.officinale ethanolic and petroleum ether 
extracts on total cholesterol LDL-C, HDL-C and TG in an induced 
hypercholesterolemic Wistar albino rats after two weeks. 
 
 
Treatment Parameter 
A B C D E 
Prob 
Cholesterol 
(mg/dl) 
205.4±20.8bc 242.6±13.1bc 286.3±52.3c 170.7±17.6b  57.7±2.1a 0.000
HDL(mg/dl) 40.0 ± 20.7a 47.6 ± 13.1a 37.1± 52.3a 39.6 ± 17.6a 39.4± 2.2a 0417 
LDL(mg/dl 148.4±16.9b 176.9± 8.3bc 214.8±38.7c 114.9±14.5b  11.3±2.0a 0.000
TG(mg/dl) 45.0±3.1c 63.6 ± 9.7a 42.1 ± 4.4c 47.3 ± 2.6bc 60.1±2.7ab 0.017
 
 
 Means ± SE within the same raw having different superscript are 
significantly different at p≤0.05. 
HDL = High density lipoprotein 
LDL = Low density lipoprotein 
TG   = Triglyceride 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
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Table (2): The effect of Z.officinale ethanolic and petroleum ether 
extracts on total cholesterol LDL-C, HDL-C and TG in an induced 
hypercholesterolemic Wister albino after 4 weeks. 
 
 
Treatment Parameter 
A B C D E 
Prob 
Cholesterol 
(mg/dl) 
193.5±33.2b 221.7±49.3b 275.5±29.4b 208.0± 21.4b 71.0± 4.6a 0.000
HDL(mg/dl) 52.6 ± 6.5a 52.4 ± 3.0a 47.8 ± 5.6a 49.8 ± 1.4a 53.1 ± 2.7a 0.809
LDL(mg/dl 125.928.9b 209.733.9c 229.3±25.3c 157.7±28.9bc 24.7 ± 4.0a 0.000
TG(mg/dl) 66.3 ± 5.0a 66.2 ± 11.7a 54.3 ± 8.2a 57.3 ± 3.5a 77.7±11.7a 0.337
 
Means ± SE within the same raw having different superscript are 
significantly different at p≤0.05. 
HDL = High density lipoprotein 
LDL = Low density lipoprotein 
TG   = Triglyceride 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received polyethylene glycol +cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
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Bars with different letters are significantly different (p ≤ 0.05). 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
Figure (5): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma total cholesterol level in an induced 
hypercholesterolemic Wistar albino rats after two weeks. 
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Bars with different letters are significantly different (p ≤ 0.05). 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
Figure (6): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma total cholesterol level in an induced 
hypercholesterolemic Wistar albino rats after 4 weeks. 
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Bars with different letters are significantly different (p ≤ 0.05). 
HDL = High density lipoprotein. 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
 
Figure (7): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma HDL-cholesterol level in an induced 
hypercholesterolemic Wistar albino rats after two weeks. 
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Bars with different letters are significantly different (p ≤ 0.05). 
HDL = High density lipoprotein. 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
Figure (8): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma HDL-cholesterol level in an induced 
hypercholesterolemic Wistar albino rats after 4 weeks. 
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Bars with different letters are significantly different (p ≤ 0.05). 
LDL = Low density lipoprotein 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
Figure (9): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma LDL-cholesterol level in an induced 
hypercholesterolemic Wistar albino rats after two weeks.  
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Bars with different letters are significantly different (p ≤ 0.05). 
LDL = Low density lipoprotein 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
Figure (10): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma LDL-cholesterol level in an induced 
hypercholesterolemic Wistar albino rats after 4 weeks. 
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Bars with different letters are significantly different (p ≤0.05). 
TG   = Triglyceride 
 
Figure (11): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma triglycerides level in an induced 
hypercholesterolemic Wistar albino rats after two weeks. 
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Bars with different letters are significantly different (p ≤ 0.05). 
TG   = Triglyceride 
A: Group (A) received orally 200mg/kg Z.officinale ethanolic extract 
+cholesterol fed. 
 B: Group (B) received orally 200mg/kg Z.officinalee petroleum ether 
extract +cholesterol fed. 
C: Group (C) received orally 200mg/kg polyethylene glycol 
+cholesterol fed. 
D: Group (D) cholesterol fed. 
E: Group (E) fed basal diet. 
 
Figure (12): The effect of ethanolic and petroleum ether extracts of Z. 
officinale on plasma triglycerides level in an induced 
hypercholesterolemic Wistar albino rats after 4 weeks. 
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3.5 The effect of ethanolic extracts of Z.officinale on blood glucose 
level in an induced hyperglycemic Wistar albino rats:- 
The plasma glucose level of group A, B and C are presented in Table 3 
and Fig 13. 
At hour 1,there was no significant difference in glucose level ,but the 
glucose level of control group (A ) was numerically higher than 
Z.officinale treated group (B)(121 vs 105.3) and glibenclamide treated 
group (C) (121 vs 106.7). 
At hour 2,The glucose level of glibenclamide treated group (C) was 
significantly lower than glucose  level of control group (A) and 
Z.officinale treated group (B).At hour 4,The glucose level of 
glibenclamide treated group (C) remained significantly lower than those 
of control group (A) and Z.officinale treated group (B).Also ,it was 
noticed ,The glucose level of Z.officinale treated group (B) increased at 
hour 4 and  was numerically higher than that of control group (A)(111.5 
vs 84.5). 
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Table (3): The effect of Z. officinale ethanolic extract and glibenclamide 
on the blood glucose level of hyperglycemic rats. 
 
 
Blood glucose concentration (mg/dl) of 
group: 
 
Sampling Time 
A B C 
Prob 
0h 73.5±10.7a 73.0±10.0a 90.6± 5.7a 0.341 
1h 121.0± 6.7a 105.3±6.9a 106.7±14.8a 0.499 
2h 105.6±16.7a 96.8±11.0a 53.0± 3.0b 0.13 
4h 84.5±16.6a 111.5±8.4a 47.9±7.9b 0.005 
 
 
Means ± SE within the same row having different superscript are 
significantly different (p ≤ 0.05). 
A: Group (A) rats received orally distilled water kept as control. 
 B: Group (B) rats received orally ethanolic extract of Zingiber 
officinale kept as treated group. 
C: Group (C) rats received orally Glibenclamide (Diabetes mellitus 
drug) and kept as diabetes mellitus drug treated control group. 
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Bars with different letters are significantly different (p ≤ 0.05). 
A: Group (A) rats received orally distilled water kept as control. 
 B: Group (B) rats received orally ethanolic extract of Zingiber 
officinale kept as treated group. 
C: Group (C) rats received orally Glibenclamide (Diabetes mellitus 
drug) and kept as diabetes mellitus drug treated control group. 
 
 
Figure (13): The effect of ethanolic extract of Z. officinale and 
glibenclamide on the blood glucose level of hyperglycemic rats. 
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CHAPTER FOUR 
DISCUSSION 
Common available Zingiber officinale preparations and different 
extractions are widely used for certain therapeutic purposes including 
interfering with inflammation processes (Ozaki et al. ,1991 )and ginger 
is listed among the herbs possessing the highest antitumor 
activities(Bode et al., 2001; Surh, 1999).The protective action of 
ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits 
was examine experimentally(Bhandari et al., 1998 ; Sharma et al., 
1996) 
Therefore, this study was designed to examine the effect of the Zingiber 
officinale extract (ethanolic and petroleum ether)on the level of plasma 
total cholesterol and its fractions (low density lipoproteins and high 
density lipoproteins) and triglycerides in an induced 
hypercholesterolemic Wistar albino rats and to examine the effect of the 
ethanolic extract on glucose plasma level in induced  hyperglycemic 
Wistar albino rats. 
Cholesterol in animal tissues occurs in the free state in an intimate 
association with the lipids, in the cell membrane and in serum 
lipoprotein. The protein proportion in lipoprotein affect cholesterol 
metabolism positively (Nishizawa et al., 1995). Dietary cholesterol 
elevates serum cholesterol and LDL cholesterol levels, but the extent of 
increase is highly variable (Giscuolo, 1994). The results of this study 
showed that plasma total cholesterol level was increased significantly 
following feeding 1% cholesterol diet in all cholesterol fed groups at 
week 2 and after 4 week. Also the feeding of cholesterol in this 
experiment increase significantly plasma LDL-cholesterol level ,the bad 
form in all cholesterol fed groups (A,B,C and D) when was compared to 
control group E, at 2 week and after 4 weeks. However, it is well known 
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that elevated level of cholesterol is associated with atherosclerosis 
(Murray et al.,1999; Stewart, 1988).In the present investigation, feeding 
of cholesterol had no significant effect on plasma HDL-cholesterol  
when cholesterol fed groups(A,B,C and D) was compared to control 
group (E) at 2 week and after 4 weeks. Also, triglyceride plasma level 
was not affected by cholesterol feed when cholesterol fed groups (A, B, 
C and D) was compared to control group (E) at week 2 and after 4 
The finding of pervious studies showed that ginger acts as a 
hypolipidemic agent in cholesterol-fed rabbits (Bhandari et al., 1998; 
Sharma et al., 1996 ; Bianca et al., 2000). Bhandari et al. (2005) 
reported that ethanolic extract of Zingiber officinale lowered serum total 
cholesterol in diabetic rats.  
The above report suggests that administration of Z.officinle to rabbits, 
rats and cell culture is effective in decreasing total cholesterol and LDL-
cholesterol. In the present investigation there was numerical increase in 
plasma total cholesterol level following administration of Zingiber 
officinale extracts at week 2 when was compared to cholesterol fed 
control group (D), but the ethanolic extract showed alittle decrease in 
plasma cholesterol level 4 week after it administration . This agrees 
with other study which showed there was no significant different in 
cholesterol concentration in Bovans chicks and albino rats treated with 
Z.officinale preparation (Ahmed, 1997). Also these findings agree with 
another study which showed ginger did not affect the blood lipids 
(Bordia et al., 1997).However, other study report that the aqueous 
extract of Z. officinale was significantly increased the relative weight of 
the testis, the serum testosterone level, testicular cholesterol level 
(Pierre et al., 2002). 
In the current study, administrated of Z.officinale extracts orally to 
induced hypercholesterolemic rats  had no significant effect in HDL-
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cholesterol level  at week 2 and 4 and this result is not in line with the 
reports which suggests that administration of  ginger to human, rats and 
cell culture is effective in increasing HDL-cholesterol( Bhandari et 
al.,2005). 
This may be due to short experimental period 4 weeks while other 
experiment period which showed significant increase was 10 weeks 
(Bhandari et al., 1998). 
The extent of activity appears to be dependent on the concentration of 
6-gingerol present in the extracts of Z.officinale (Kadnur et al., 
2005).The ginger used in this experiment was purchased from the 
market, may be an old stock which contain low concentration of 
gingerol. However this study agrees with other study which showed, 
ginger did not affect the blood lipids (Bordia et al., 1997). 
In the present study Z.officinale ethanolic extract caused numerical 
increased in plasma LDL-cholesterol levels at week 2 but numerical 
decreased of LDL (125.vs 157) at week 4.The petroleum ether extract 
increased numerically LDL at week 2 and week 4 when was compared 
to cholesterol control group . These results disagree with Bhandari  et al 
(1998) who reported marked rise in serum that followed 10 weeks of 
cholesterol feeding to rabbits was significantly reduced by the ethanolic 
ginger extract. In other study (Bianca et al., 2000) reported that, ginger 
extract consumption reduces plasma cholesterol, inhibits LDL oxidation 
and attenuates development of atherosclerosis in atherosclerotic .This 
finding is in line with Sharma et al. (1998). However Bordia et al. 
(1997) reported that ginger did not affect the blood lipids.  
Triacylglycerols has a role in lipid transport and storage and in many 
diseases such as obesity and diabetes mellitus, but it is lesser correlated 
to coronary heart disease than the cholesterol (Murray et al., 1999).  
Triacylglycerols function is the storage and liberation of metabolic 
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energy and is the dominant lipid class in animal fat (Antonio and David, 
1989).In the current study, administrated of Z.officinale petroleum ether 
extract orally to an induced hypercholesterolemic rats had no significant 
effect in triglycerides level at week 2 and 4 when was compared to 
control group (E) while ethanolic extract had significant effect both at 
week 2 and 4 when was compared to control group (E). And this result 
is not in line with the reports which suggests ginger acting as a 
hypolipidemic agent in cholesterol-fed rabbits (Bhandari et al.,1998; 
Sharma et al. ,1996 ). 
This might be due to short experiment period 4 week when compared to 
effect of long experiment period 10 weeks (Bhandari et al.,1998 ).  
The effect of ethanolic extract of Z.officinale on glucose loaded rats was 
tested .The ginger ethanolic extract did not show hypoglycemic effect 
on the rats loaded with glucose  at hour 2 and 4 and this result is in line 
with  the  report which showed  administration of ginger did not affect 
the blood lipids and blood sugar (Bordia et al., 1997), but disagree  with 
Kar et al.( 2003) who reported  that ginger lowered glucose level within 
two weeks in  alloxan diabetic rats  and also disagree with Bhandari et 
al. (2005) who reported that ethanolic extract of Zingiber officinale 
(200 mg/kg) fed orally for 20 days produced significant 
antihyperglycaemic effect (P < 0.01) in diabetic rats.  
 The increase in blood glucose  of ethanolic extract treated group (B) at  
hour 4 is not easily to explained  but may be due to Z.officinale content 
of carbohydrate .In this investigation, Glibenclamide drug which is 
commonly used for treatment of type 2 diabetes mellitus reduced 
significantly glucose plasma level at 2 hour and 4 hour when compared 
to control group (A) and Z.officinale ethanolic extract treated group 
(B).Thus it seems Z.officinale ethanolic extract is not so potent herb 
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extract which could be used as hypoglycemic agent to replace the 
commonly used antidiabetic drugs such as glibenclamide. 
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CONCLUSIONS AND RECOMMENDATIONS 
Conclusions:- 
From the observations and results of this investigation it can be 
concluded that: 
• Administration of ginger extract orally to an induced 
hypercholesterolemic rat's increased total cholesterol numerically 
at week 2 and after 4weeks. 
• Administration of Z.officinale extracts orally to an induced 
hypercholesterolemic rat had no significant effect in HDL-
cholesterol level at week 2 and after 4weeks. 
• Z.officinale extracts caused at week 2  numerical increased in 
plasma LDL-cholesterol levels .At week 4  and ginger petroleum 
ether extract caused numerical increased while ethanolic extract 
caused numerical decrease . 
• Administration of Z.officinale extracts orally to an induced 
hypercholesterolemic rat had no significant effect in triglycerides 
level at week2 and 4 but ethanolic extract had significant effect at 
week 2. 
• The ginger ethanolic extract did not show hypoglycemic effect. 
 
Recommendations: 
From the results and discussion of this study it is recommended that: 
1. Further research should be carried out to examine the effect 
petroleum ether, ethanolic and water extracts of fresh or new stock of 
Z.officinale.   
2. The experiment should continue for longer period not less than 10 
weeks to examine hypolipidemic, hypoglycemic and harmful effect if 
present.  
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